Find and Pitch Jounalists, Get Your Story Covered

Tags: MDMA ecstasy PTSD therapy care continuum communication

	Profile	Recent Articles on Subject
1	Associated Press MedPage Today Explains healthcare complexities. Not endorsements. New York, New York Healthcare journalism	Nearly 2,000 Pharmaceutical Plants Are Overdue for FDA Checks After COVID Delays - 14 days ago
2	Amy Baxter Pharma Voice Scientist, inventor, former pediatrician. Atlanta, Georgia pain relieftechnologyinnovation	The drugs hit hardest by Medicare price negotiations - about 1 month ago Cutting pills. Rationing insulin. How Americans struggle to pay for drugs. - 5 months ago After ‘tragic’ bacterial outbreak, lawmakers press FDA to step up foreign inspections - 7 months ago
3	Nick Paul Taylor MedTech Dive Top 5 Mario Kart Player. Gaming	FDA warns BD blood culture bottle shortage could impact diagnosis - 2 months ago FDA expands import alert to block all plastic syringes from Chinese manufacturer - 5 months ago Supply disruptions are delaying surgeries and compromising patient care, survey finds - 11 months ago
4	Alana Hippensteele, Managing Editor Pharmacy Times #pharmacy news, insights. CE provider. Cranbury, New Jersey pharmacyhealthcarejournalism	During Drug Shortages, There Are Resources so Pharmacists ‘Never Need to Ration Life-Saving Drugs’ - 3 months ago
5	Mike Hennessy Jr, President and CEO Pharmacy Times Pro middleweight boxer. UK/Ireland. BoxingSports	Navigating Oncology Drug Shortages: Ethical Frameworks and Strategic Management - 3 months ago
6	Joseph L. Fink III, JD, DSC (Hon.), BSPHARM, FAPhA Pharmacy Times Podcasts creator, books author. Not here often. podcastingwriting	Pharmacy Closures Spark Need for PBM Reform - 4 months ago
7	John Wilkerson STAT News STAT Washington correspondent. Healthcare Journalism	STAT+: Senate drug shortage bill would pay hospitals bonuses for good contracting practices - 5 months ago STAT+: The White House has a plan to stem drug shortages - 6 months ago STAT+: Key Senate panel considers Medicare bonuses for hospitals that prevent drug shortages - 8 months ago STAT+: Senate panel considers Medicare policy fixes to drug shortages - 10 months ago STAT+: Cancer drug shortages won’t get better under Biden’s latest plan - 10 months ago STAT+: Biden invokes Defense Production Act to stem drug shortages - 10 months ago STAT+: Europe takes steps to head off drug shortages, even as U.S. proposals stall - 11 months ago STAT+: Pharmacists can make shortage drugs, but at what cost? - 11 months ago
8	Ed Silverman STAT News Pharmalot columnist. Senior writer at STATnews. pharmaceutical industry	STAT+: Pharmalittle: We’re reading about drug shortages, Medicare spending on an Alzheimer’s drug, and more - 5 months ago STAT+: Pharmalittle: We’re reading about biotech startups, Pfizer’s RSV vaccine, and more - 5 months ago STAT+: Pharmalittle: We’re reading about a White House drug-shortage plan, a Genmab deal, and more - 6 months ago STAT+: Pharmalittle: We’re reading about Europe’s pharma reform, weight-loss meds, and more - 6 months ago STAT+: Pharmalittle: We’re reading about a Lilly obesity-drug ad, a $35 cap on inhalers, and more - 7 months ago STAT+: Pharmalittle: We’re reading about a nixed Medicare negotiation lawsuit, an Obamacare challenge, and more - 7 months ago STAT+: Many costly generic drugs are unavailable at Amazon, Cuban, and other alternative pharmacies - 7 months ago STAT+: Pharmalittle: We’re reading about state moves on drug pricing, an asthma med for kids and more - 7 months ago STAT+: A lawsuit over a controversial Sanofi drug shortage is unexpectedly revived - 7 months ago STAT+: Major generic maker Aurobindo cuts production at a key plant amid concerns over shortages - 7 months ago STAT+: Pharmalittle: We’re reading about Medicaid and sickle cell, pharma CEOs, and more - 8 months ago STAT+: Pharmalittle: We’re reading about Sanders jabbing Merck’s CEO, fixing drug shortages, and more - 8 months ago STAT+: Pharmalittle: We’re reading about drug price hikes, Bayer strategic moves, and more - 8 months ago STAT+: Pharmalittle: We’re reading about GLP-1 drugs’ safety, Novartis nixing a deal, and more - 8 months ago STAT+: Pharmalittle: We’re reading about FDA’s syphillis-drug plan, India’s manufacturer-inspection demands, and more - 8 months ago STAT+: Pharmalittle: We’re reading about Lilly selling drugs directly, UCB leaving BIO, and more news - 9 months ago STAT+: Pharmalittle: Drugmakers raise prices, pharmacies fear fees, McKinsey settles - 9 months ago STAT+: Pharmalittle: U.S. to impose inflation penalties on dozens of drugmakers; Supreme Court will decide abortion pill access - 9 months ago STAT+: Pharmalittle: Sanofi scraps rare-disease drug deal under FTC pressure; patients regain weight after stopping Lilly’s Zepbound - 9 months ago STAT+: Pharmalittle: CVS to overhaul how it’s paid for drugs; Biden drug-shortage plan won’t expand chemo supplies - 10 months ago STAT+: Pharmalittle: More U.S. states and cities are suing insulin makers; Biden looks to boost U.S. drug manufacturing amid shortages - 10 months ago STAT+: Pharmalittle: German regulator eyes Ozempic export ban amid shortages; NIH-funded clinical trials lagging pharma’s in enrollment - 10 months ago STAT+: Pharmalittle: Pharma trade group slams European Commission proposal; U.S. lawmakers demand FDA explain its approach to shortages - 11 months ago STAT+: Pharmalittle: U.S. Senate eyes more policies for regulating PBMs; Novo claims most U.S. Wegovy patients pay less than $25 a month - 11 months ago STAT+: Health plan formularies lowered barriers to fair access to some drugs, analysis finds - 11 months ago STAT+: Pharmalittle: Rite Aid files for bankruptcy; Alzheimer’s brain scans get broader Medicare coverage - 11 months ago STAT+: Medicare may plan to negotiate drug prices, but some states are taking their own steps to lower costs - 11 months ago STAT+: Pharmalittle: Novo faces patent challenge on Wegovy and Ozempic; Senate panel moves to address drug shortages - 12 months ago STAT+: Pharmalittle: More than 9 in 10 pharmacy techs report drug shortages; Yale and VA strike deal over ketamine patent royalties - 12 months ago STAT+: Lilly sues compounders, wellness centers and spas over unapproved versions of Mounjaro - 12 months ago STAT+: Pharmalittle: U.S. Chamber and feds clash on Medicare price negotiation; South Africa probes J&J over TB-drug pricing - about 1 year ago
9	Sophie Putka MedPage Today Enterprise, investigative writer. New York, USA enterprise journalisminvestigative journalism	Weight-Loss Drug Zepbound Faces Supply Issues - 6 months ago
10	Dan Goodin Ars Technica Follow on Mastodon. San Francisco, California technologysecurity	US prescription market hamstrung for 9 days (so far) by ransomware attack - 7 months ago

Journalists covering drug shortages